Tate & Lyle research reveals new consumer insights in the GLP-1 era

| Filed in:

Tate & Lyle has released new consumer research exploring how GLP-1 medications are reshaping eating behaviours and what food and beverage manufacturers can do to meet evolving consumer expectations.

12 November 2025, Chicago, IL, US: Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and drink, is releasing new consumer research exploring how GLP-1 medications are reshaping eating behaviours - and what food and beverage manufacturers can do to meet evolving consumer expectations.

Conducted among 500 active and former GLP-1 users across North America (T&L Proprietary GLP-1 research study May 2025), the proprietary research set out to identify unmet consumption needs and support healthier, more sustainable long-term habits.

“GLP-1 medications are redefining the eating experience,” said Anisha Banerjee, Global Insights and Analytics, Tate & Lyle. “Our research reveals how taste, texture and satiety preferences are evolving; and how manufacturers can meet the moment with products that deliver nutrition and genuine enjoyment.”

 

A Transformational Shift, Not a Passing Trend

Tate & Lyle’s findings reinforce that GLP-1s represent more than a temporary fad. For food and beverage makers, this shift presents exciting opportunities to lead with better-for-you innovation and more permissibly indulgent, satisfying and nutritionally balanced formulations.

 

Key Takeaways from Tate & Lyle’s 2025 GLP-1 Consumer Research

  • A Familiar Arc Emerges: GLP-1 users follow a recognizable pattern of momentum, maintenance and regression. Understanding behaviours at each stage helps brands target product formulation and adoption strategies that promote lasting success for GLP-1 users.
  • Food Joy Returns: Current GLP-1 users seek joyful, sensory food experiences — indulgent, comforting textures in smaller, nutrient-dense portions. “Food joy” comes from products that feel satisfying while supporting nutritional needs.
  • Combating Food Noise: Former users face a resurgence of appetite and “food noise.” Satisfying, fibre-rich and protein-fortified foods can help manage this return to hunger and support weight-management continuity.
  • Permissible Indulgence: Sustainable habits require options that balance pleasure and nutrition. Low- and no-sugar products, especially those with added fibre, offer a route to permissible indulgence.
  • Mouthfeel Matters: Consumers increasingly look for gentle, comforting snack textures with airy or crispy sensations. Layering different mouthfeel experiences — crispy, crunchy, creamy — helps restore enjoyment in smaller portions. New studies are trying to quantify the impact of texture on eating rate. A slower eating rate can impact feelings of fullness and total intake, making texture an important consideration for the food industry when helping former GLP-1 users who are looking for satiety.
  • Timing Is Everything: Willingness to adopt healthier diet changes is 2.5x higher among early GLP-1 users than late-stage users, highlighting a crucial moment for brands to build loyalty and drive trial.

 

Opportunities for Food and Beverage Manufacturers

The research highlights two major opportunities for innovation:

  1. Supporting Former GLP-1 Users: Helping consumers manage returning hunger and “food noise” through satiety-enhancing formulations.
  2. Designing Permissible Indulgence: Delivering nutrient-dense, smaller portions that are  satisfying through smart ingredient and texture design.

“With our deep formulation expertise and a portfolio that spans sweeteners, fibres and plant-based texturants, Tate & Lyle is uniquely positioned to help manufacturers create products that are both healthy and delicious,” said Emma Cahill, Platform Marketing Director, Sweeteners & Fibre. “We can help our customers make healthy food tastier and tasty food healthier to help consumers on their quest to make new habits stick.”

 

About Tate & Lyle

Tate & Lyle is a leading global provider of ingredient solutions that make food and drink healthier and tastier. Through its portfolio of sweeteners, fibres, and texturants, Tate & Lyle partners with manufacturers to support balanced diets and sustainable nutrition across more than 120 countries.

For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedInX (Twitter)Facebook or YouTube

For more information on Tate & Lyle’s GLP-1 consumer research or to schedule an interview, please contact:
Kate Joachim

[email protected] 

Click here for our press image gallery

About Tate & Lyle PLC:  

Supported by our 165-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients and solutions every day.  

Through our leading expertise in sweetening, mouthfeel and fortification, we develop ingredients and solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability to food and drink in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.  

Tate & Lyle recently acquired CP Kelco, a leading provider of pectin, speciality gums and other nature-based ingredients to create a leader in mouthfeel, significantly enhancing our solutions capabilities. Following this combination, we now have more than 5,000 employees working in around 75 locations in 38 countries, serving customers in more than 120 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives through the Science of Food. By living our purpose, we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.  

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31 March 2025, and on a pro forma basis which assumes for illustrative purposes that the combination with CP Kelco took place on 1 April 2024, revenue for the enlarged Tate & Lyle Group would have been £2.12 billion. For more information, please visit www.tateandlyle.com or follow Tate & Lyle on LinkedIn, X (Twitter), Facebook or YouTube